𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The value of immersion hand radiography in soft tissue changes of musculoskeletal disorders

✍ Scribed by Caroline Ngo; Issa Yaghmai

Publisher
Springer
Year
1988
Tongue
English
Weight
477 KB
Volume
17
Category
Article
ISSN
0364-2348

No coin nor oath required. For personal study only.

✦ Synopsis

Immersion hand radiographs were performed on 25 patients with various clinical presentations and compared to plain radiographic studies of the hands. The immersion technique is superior in outlining the skin, subcutaneous fat layers, and fat layers between muscle planes. More important, this technique highlights the tendons and soft tissue components of the joint, which are hardly seen on standard hand radiographs. Immersion studies are therefore useful, both in the early diagnosis of erosive arthritis and in the follow-up of the course of the disease. They are recommended as an adjunct to conventional hand radiography in musculoskeletal disorders with soft tissue involvement.

πŸ“œ SIMILAR VOLUMES

The value of angiography in soft tissue
The value of angiography in soft tissue leiomyosarcomas of the extremities
✍ L. Ekelund; A. Rydholm πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 979 KB

The angiographic findings in eight patients with soft tissue leiomyosarcoma of the extremities are presented. All tumours were hypervascular. Vascular compression was seen in four tumours and intravenous tumour growth could be demonstrated in three. These findings are of great value in the planning

Use of antibiotics in the initial manage
Use of antibiotics in the initial management of soft tissue hand wounds
✍ Robert E. Haughey; Richard L. Lammers; David K. Wagner πŸ“‚ Article πŸ“… 1981 πŸ› Elsevier Science 🌐 English βš– 535 KB

A prospective, randomized study was undertaken to determine the efficacy of prophylactic antibiotics in the treatment of various types of soft tissue hand wounds. A total of 394 patients were randomly assigned to one of two treatment groups, those receiving cephalexin (250 mg orally q.i.d, x 5 days)